For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, such therapies often remain ineffective. Now Japanese scientists are providing a possible way out: a combination of two bacteria that control each other and attack cancer even without the help of the immune system.
The new therapy could help above all those people whose immune system is exhausted after cancer therapy – and for whom there are hardly any treatment options so far.
Two microbes, one task
A research team led by Eijiro Miyako from the Japan Advanced Institute of Science and Technology has combined two natural bacterial species: Proteus mirabilis and Rhodopseudomonas palustris. In a ratio of three to 97 percent, they form a consortium that the researchers call "AUN" – after a Japanese term for harmony.
These two microbes behave like partners: Proteus mirabilis penetrates deep into tumor tissue and changes its shape there to attack cancer cells. Rhodopseudomonas palustris regulates the process and prevents the bacteria from getting out of control or triggering inflammation. This creates a finely balanced balance that destroys tumors from the inside out, but spares healthy tissue.
"After 150 years, a new chapter in bacteria-based cancer therapy is finally beginning," says study leader Miyako. He is alluding to the fact that scientists first researched bacterial cancer treatment 150 years ago.
"Suffocating" the tumor
In the study published in the journal Nature Biomedical Engineering, the scientists investigated what happens in the body when AUN enters the bloodstream. The bacteria find their way to the tumour and begin to change its blood supply. Small clots form in the fine vessels, which only occur in the tumour tissue. As a result, the cancer is cut off from oxygen – it "suffocates" from the inside.
At the same time, the bacteria form fibre-like structures with which they directly attack cancer cells. This combined effect leads to a massive necrosis, i.e. to the death of the tumour tissue.
Teamwork significantly increases the impact
The team found that a two-stage treatment is particularly effective: first a small dose to accustom the immune system to the bacteria, followed by a higher dose. This procedure led to a complete decrease in tumours in all experiments – while at the same time being well tolerated.
Hope even for weak patients
Classic immunotherapies, such as so-called checkpoint inhibitors or CAR-T cell therapies, only work when the body's own defences are intact. In people who have already had several chemotherapy treatments, they usually remain unsuccessful. This is exactly where the new concept cats in: The bacteria attack tumours independently of Defence cells.
In the study, the researchers reported:
AUN completely eliminated tumours – even in animals whose immune system was barely active.
This opens up a completely new way of treatment for patients who have previously had no chance of immunotherapy.
No genetically modified microbes
Particularly remarkable: The researchers did not have to genetically modify the microbes. Both species exist in nature – Proteus mirabilis can also be found in small quantities in the human body, Rhodopseudomonas palustris in soils and waters.
They adapt in the tumour environment: one bacterium becomes more mobile and aggressive, the other ensures that the attack remains targeted. If unwanted reactions occur, the system can be stopped with common antibiotics. This could make the use for patients one day much safer than previous bacterial therapies.
Clinical study planned
The method is not yet approved for clinical practice. The team around Miyako is currently preparing the first studies with humans. In the coming years, safety, dosage and efficacy are to be tested.
The goal is to develop a therapy that fights tumours regardless of the state of the immune system. If this succeeds, AUN therapy could create a new treatment option – for those patients who previously had no hope of recovery.
Summary:
- A Japanese study shows that two naturally occurring bacteria can destroy cancer without needing the immune system.
- The bacteria specifically block the blood supply to cancer cells and trigger their death, while healthy cells are spared.
- The method is considered a hope for patients whose immune system is severely weakened after chemotherapy or radiation therapy.
Von Anne Bajrica
The original of this article "New bacterial therapy destroys cancer even with a weakened immune system" comes from Smart Up News.
News
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]
Multifunctional Nanogels: A Breakthrough in Antibacterial Strategies
Antibiotic resistance is a growing concern - from human health to crop survival. A new study successfully uses nanogels to target and almost entirely inhibit the bacteria P. Aeruginosa. Recently published in Angewandte Chemie, the study [...]
